Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5,6-DiMethoxyindoline is an organic compound characterized by its indoline structure with two methoxy groups attached at the 5th and 6th positions. It is a versatile intermediate in the synthesis of various chemical compounds and has potential applications in the pharmaceutical and chemical industries.

15937-07-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 15937-07-2 Structure
  • Basic information

    1. Product Name: 5,6-DiMethoxyindoline
    2. Synonyms: 5,6-DiMethoxyindoline;1H-INDOLE, 2,3-DIHYDRO-5,6-DIMETHOXY;6-broMo-7-MethyliMidazo[1,2-b]pyridazine;2,3-dihydro-5,6-diMethoxy-1H-Indole;5,6-diMethoxy-2,3-dihydro-1H-indole
    3. CAS NO:15937-07-2
    4. Molecular Formula: C10H13NO2
    5. Molecular Weight: 179.21572
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 15937-07-2.mol
  • Chemical Properties

    1. Melting Point: 105℃ (benzene )
    2. Boiling Point: 301.244°C at 760 mmHg
    3. Flash Point: 116.88°C
    4. Appearance: /
    5. Density: 1.102g/cm3
    6. Vapor Pressure: 0.001mmHg at 25°C
    7. Refractive Index: 1.534
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. PKA: 5.72±0.20(Predicted)
    11. CAS DataBase Reference: 5,6-DiMethoxyindoline(CAS DataBase Reference)
    12. NIST Chemistry Reference: 5,6-DiMethoxyindoline(15937-07-2)
    13. EPA Substance Registry System: 5,6-DiMethoxyindoline(15937-07-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 15937-07-2(Hazardous Substances Data)

15937-07-2 Usage

Uses

Used in Pharmaceutical Industry:
5,6-DiMethoxyindoline is used as a key intermediate in the synthesis of biphenyl derivatives, which are important for the treatment of obstructive airways disease. Its unique structure allows for the development of novel therapeutic agents that can potentially improve the management of respiratory conditions.
Used in Chemical Industry:
5,6-DiMethoxyindoline serves as a valuable building block for the creation of various chemical compounds, including those with potential applications in materials science, agrochemicals, and other specialized fields. Its reactivity and structural diversity make it a useful component in the development of new molecules with specific properties and functions.

Synthesis Reference(s)

Journal of Medicinal Chemistry, 21, p. 548, 1978 DOI: 10.1021/jm00204a009

Check Digit Verification of cas no

The CAS Registry Mumber 15937-07-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,9,3 and 7 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 15937-07:
(7*1)+(6*5)+(5*9)+(4*3)+(3*7)+(2*0)+(1*7)=122
122 % 10 = 2
So 15937-07-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO2/c1-12-9-5-7-3-4-11-8(7)6-10(9)13-2/h5-6,11H,3-4H2,1-2H3

15937-07-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,6-Dimethoxyindoline

1.2 Other means of identification

Product number -
Other names 5,6-dimethoxy-2,3-dihydro-1H-indole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15937-07-2 SDS

15937-07-2Synthetic route

5,6-dimethoxyindole
14430-23-0

5,6-dimethoxyindole

5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

Conditions
ConditionsYield
With sodium cyanoborohydride; acetic acid for 0.5h; Ambient temperature;92%
With sodium cyanoborohydride; acetic acid for 1.25h; Ambient temperature;80%
With sodium cyanoborohydride; acetic acid at 20℃; for 1h;56%
With sodium cyanoborohydride; acetic acid at 20℃; for 1h;
2-(3,4-dimethoxyphenyl)-ethylamine
120-20-7

2-(3,4-dimethoxyphenyl)-ethylamine

5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

Conditions
ConditionsYield
With naphthalene-1,4-dicarbonitrile; oxygen In methanol Irradiation; or with 9,10-dihydroanthracene, MeCN;80%
2-(2-bromo-4,5-dimethoxyphenylphenyl)ethan-1-amine
63375-81-5

2-(2-bromo-4,5-dimethoxyphenylphenyl)ethan-1-amine

5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

Conditions
ConditionsYield
With copper(l) iodide; potassium carbonate; L-proline In dimethyl sulfoxide at 70℃; for 45h; Inert atmosphere;36%
2,2,2-trifluoro-N-<2-(2-iodo-4,5-dimethoxyphenyl)ethyl>acetamide
154138-43-9

2,2,2-trifluoro-N-<2-(2-iodo-4,5-dimethoxyphenyl)ethyl>acetamide

5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

Conditions
ConditionsYield
With potassium carbonate In methanol at 25 - 26℃; Inert atmosphere; Reflux;
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

5,6-dimethoxyindole
14430-23-0

5,6-dimethoxyindole

Conditions
ConditionsYield
With dichloro[1,3-bis(2-methylphenyl)-2-imidazolidinylidene](benzylidene) (tricyclohexylphosphine) ruthenium(II); oxygen In ethyl acetate at 70℃; under 760.051 Torr; for 46h; Reagent/catalyst; Solvent; Sealed tube;82%
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

2-(4-bromobutyl)isoindoline-1,3-dione
5394-18-3

2-(4-bromobutyl)isoindoline-1,3-dione

C22H24N2O4
1313202-17-3

C22H24N2O4

Conditions
ConditionsYield
With potassium carbonate; sodium iodide at 60℃; for 2h;74%
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

4-Fluoronitrobenzene
350-46-9

4-Fluoronitrobenzene

5,6-dimethoxy-1-(4-nitrophenyl)-indoline
441349-89-9

5,6-dimethoxy-1-(4-nitrophenyl)-indoline

Conditions
ConditionsYield
With sodium bicarbonate In dimethyl sulfoxide65.6%
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

5,6-dihydroxyindoline hydrobromide

5,6-dihydroxyindoline hydrobromide

Conditions
ConditionsYield
With hydrogen bromide at 140℃; for 3h;62%
2-chloro-5-nitropyridine
4548-45-2

2-chloro-5-nitropyridine

5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

5,6-Dimethoxy-1-(5-nitro-(2-pyridyl))-indoline
441349-90-2

5,6-Dimethoxy-1-(5-nitro-(2-pyridyl))-indoline

Conditions
ConditionsYield
With sodium bicarbonate In dimethyl sulfoxide23.1%
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

2,4-Diamino-5-methyl-pyrido[2,3-d]pyrimidine-6-carbaldehyde; compound with acetic acid

2,4-Diamino-5-methyl-pyrido[2,3-d]pyrimidine-6-carbaldehyde; compound with acetic acid

6-(5,6-Dimethoxy-2,3-dihydro-indol-1-ylmethyl)-5-methyl-pyrido[2,3-d]pyrimidine-2,4-diamine

6-(5,6-Dimethoxy-2,3-dihydro-indol-1-ylmethyl)-5-methyl-pyrido[2,3-d]pyrimidine-2,4-diamine

Conditions
ConditionsYield
With hydrogenchloride; 4 A molecular sieve; sodium cyanoborohydride 1.) MeOH, 6 h, 2.) MeOH, 22 h; Yield given. Multistep reaction;
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

4-(5,6-dimethoxyindolin-1-yl)butan-1-amine
1285549-15-6

4-(5,6-dimethoxyindolin-1-yl)butan-1-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate; sodium iodide / 2 h / 60 °C
2: hydrazine hydrate / methanol / 3 h / Reflux
View Scheme
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

5-bromo-N-(4-(5,6-dimethoxyindolin-1-yl)butyl)-2,3-dimethoxybenzamide
1285548-89-1

5-bromo-N-(4-(5,6-dimethoxyindolin-1-yl)butyl)-2,3-dimethoxybenzamide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate; sodium iodide / 2 h / 60 °C
2: hydrazine hydrate / methanol / 3 h / Reflux
3: triethylamine / dichloromethane / 20 °C
View Scheme
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

1-(2-(5,6-dimethoxyindolin-1-yl)ethyl)-1H-pyrazol-4-amine
1394162-05-0

1-(2-(5,6-dimethoxyindolin-1-yl)ethyl)-1H-pyrazol-4-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium tris(acetoxy)borohydride / dichloromethane / 1 h / 20 °C
2: hydrogen / platinum(IV) oxide / methanol / 1 h / 20 °C
View Scheme
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

1-[2-(5,6-dimethoxy-indol-1-yl)-ethyl]-1H-pyrazol-4-ylamine
1394162-06-1

1-[2-(5,6-dimethoxy-indol-1-yl)-ethyl]-1H-pyrazol-4-ylamine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: sodium tris(acetoxy)borohydride / dichloromethane / 1 h / 20 °C
2: hydrogen / platinum(IV) oxide / methanol / 1 h / 20 °C
3: manganese(IV) oxide / acetone / 20 °C
View Scheme
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

2-(4-nitro-1H-pyrazol-1-yl)acetaldehyde
1015939-59-9

2-(4-nitro-1H-pyrazol-1-yl)acetaldehyde

5,6-dimethoxy-1-(2-(4-nitro-1H-pyrazol-1-yl)ethyl)indoline
1394162-04-9

5,6-dimethoxy-1-(2-(4-nitro-1H-pyrazol-1-yl)ethyl)indoline

Conditions
ConditionsYield
Stage #1: 5,6-dimethoxyindoline; 2-(4-nitro-1H-pyrazol-1-yl)acetaldehyde With sodium tris(acetoxy)borohydride In dichloromethane at 20℃; for 1h;
Stage #2: With water In dichloromethane
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

C16H14N2O3*BrH

C16H14N2O3*BrH

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: acetonitrile / 20 °C
2.1: boron tribromide / dichloromethane / 3 h / -78 - 25 °C / Inert atmosphere
2.2: 0.5 h / 0 °C
3.1: hydrogen bromide / water / 2.5 h / 0 - 25 °C
View Scheme
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

C16H14N2O3*ClH

C16H14N2O3*ClH

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: acetonitrile / 20 °C
2.1: boron tribromide / dichloromethane / 3 h / -78 - 25 °C / Inert atmosphere
2.2: 0.5 h / 0 °C
3.1: hydrogenchloride / methanol / 2.5 h / 0 - 25 °C
View Scheme
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

5-(5,6-dimethoxyindolin-1-yl)-6-methoxy-1H-indole

5-(5,6-dimethoxyindolin-1-yl)-6-methoxy-1H-indole

Conditions
ConditionsYield
In acetonitrile at 20℃;11.5 g
5,6-dimethoxyindoline
15937-07-2

5,6-dimethoxyindoline

1-(6-hydroxy-1H-indol-5-yl)indoline-5,6-diol

1-(6-hydroxy-1H-indol-5-yl)indoline-5,6-diol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: acetonitrile / 20 °C
2.1: boron tribromide / dichloromethane / 3 h / -78 - 25 °C / Inert atmosphere
2.2: 0.5 h / 0 °C
View Scheme

15937-07-2Relevant articles and documents

Regiospecific dihydroindoles directly from β-arylethylamines by photoinduced SET reaction: One pot 'wavelength switch' approach to benzopyrrolizidines related to mitomycin

Pandey,Sridhar,Bhalerao

, p. 5373 - 5376 (1990)

Regiospecific highly substituted indole derivatives are synthesised by photoinduced SET initiated cyclisation of β-arylethylamines and development of sequential one pot approach to benzopyrrolizidines related to mitomycin at two different wavelengths under SET conditions is reported.

Aerobic Dehydrogenation of N-Heterocycles with Grubbs Catalyst: Its Application to Assisted-Tandem Catalysis to Construct N-Containing Fused Heteroarenes

Kawauchi, Daichi,Noda, Kenta,Komatsu, Yoshiyuki,Yoshida, Kei,Ueda, Hirofumi,Tokuyama, Hidetoshi

supporting information, p. 15793 - 15798 (2020/10/12)

An aerobic dehydrogenation of nitrogen-containing heterocycles catalyzed by Grubbs catalyst is developed. The reaction is applicable to various nitrogen-containing heterocycles. The exceptionally high functional group compatibility of this method was confirmed by the oxidation of an unprotected dihydroindolactam V to indolactam V. Furthermore, by taking advantage of the oxygen-mediated structural change of the Grubbs catalyst, we integrated ring-closing metathesis and subsequent aerobic dehydrogenation to develop the novel assisted-tandem catalysis using molecular oxygen as a chemical trigger. The utility of the assisted-tandem catalysis was demonstrated by the concise synthesis of N-containing fused heteroarenes including a natural antibiotic, pyocyanine.

Compound for hair dyeing and single dosage type hair dye containing compound

-

Paragraph 0049; 0051; 0052; 0053; 0054, (2018/09/21)

The invention relates to a compound for hair dyeing and single dosage type hair dye containing the compound. The compound has a structure formula shown as a formula I or a formula II shown in description, wherein X in the formula II is Br or Cl. The raw material compound provided by the invention has the beneficial effects that 1, new raw materials can easily permeate into hair and are subjected to auto-oxidation polymerization in air inside the hair; melanin generating natural black achieves a dyeing effect; the advantages of fast coloring and coloring durability are realized; the generated melanin is a polymer; the melanin pre se is a substance generated by human body melanin cells and cannot reversely enter the human body in the hair; 2, the new raw materials and the hair dye provided by the invention have a good dyeing effect; particularly universality is realized; human hair with various colors such as white color, grey white color, faint yellow color, golden yellow color and redcolor can be dyed into natural black.

NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS

-

Page/Page column 44, (2012/09/10)

The present invention relates to pyrazole and imidazole derivatives of formula (I) wherein U, V, L, X, Y, R1, (R2)n and (R3)m and ring A are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as orexin receptor antagonists.

Effect of structural modification in the amine portion of substituted aminobutyl-benzamides as ligands for binding σ1 and σ2 receptors

Fan, Kuo-Hsien,Lever, John R.,Lever, Susan Z.

experimental part, p. 1852 - 1859 (2011/05/02)

5-Bromo-N-[4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-butyl)]-2, 3-dimethoxy-benzamide (1) is one of the most potent and selective σ2 receptor ligands reported to date. A series of new analogs, where the amine ring fused to the aromatic ring was varied in size (5-7) and the location of the nitrogen in this ring was modified, has been synthesized and assessed for their σ1/σ2 binding affinity and selectivity. The binding affinity of an open-chained variant of 1 was also evaluated. Only the five-membered ring congener of 1 displayed a higher σ1/σ2 selectivity, derived from a higher σ2 affinity and a lower σ1 affinity. Positioning the nitrogen adjacent to the aromatic ring in the five-membered and six-membered ring congeners dramatically decreased affinity for both subtypes. Thus, location of the nitrogen within a constrained ring is confirmed to be key to the exceptional σ2 receptor binding affinity and selectivity for this active series.

Synthesis and biological evaluation of nonclassical 2,4-diamino-5- methylpyrido[2,3-d]pyrimidines with novel side chain substituents as potential inhibitors of dihydrofolate reductases

Gangjee, Aleem,Vasudevan, Anil,Queener, Sherry F.

, p. 479 - 485 (2007/10/03)

Nine novel 2,4-diamino-5-methyl-6-substituted-pyrido[2,3-d]pyrimidines, 2-10, were synthesized as potential inhibitors of Pneumocystis carinii dihydrofolate reductase (pcDHFR) and Toxoplasma gondii dihydrofolate reductase (tgDHFR). Compounds 2-5 were designed as conformationally restricted analogues of trimetrexate (TMQ), in which rotation around τ3 was constrained by incorporation of the side chain nitrogen as part of an indoline or an indole ring. Analogue 6, which has an extra atom between the side chain nitrogen and the phenyl ring, has its nitrogen as part of a tetrahydroisoquinoline ring. Analogues 7-9 are epiroprim (Ro 11-8958) analogues and contain a pyrrole ring as part of the side chain substitution on the phenyl ring similar to epiroprim. These analogues were designed to investigate the role of the pyrrole substitution on the phenyl ring of 2,4- diamino-5-methyl-6-(anilinomethyl)pyrido[2,3-d]pyrimidines. Molecular modeling indicated that a pyrrole substituent in the ortho position of the side chain phenyl ring was most likely to interact with pcDHFR in a manner similar to the pyrrole moiety of epiroprim. Analogue 10, in which a phenyl ring replaced a methoxy group, was synthesized to determine the contribution of a phenyl ring on selectivity, lipophilicity, and cell penetration. The synthesis of analogues 2-4 was achieved via reductive amination of 2,4- diamino-5-methyl 6-carboxaldehyde with the appropriately substituted indolines. The indolines were obtained from the corresponding indoles via NaCNBH3 reductions. Analogues 5-10 were synthesized by nucleophilic displacement of 2,4-diamino-5-methyl-6-(bromemethyl)-pyrido[2,3-d]pyrimidine with the 5-methoxyindolyl anion, 6,7-dimethoxytetrahydroisoquinoline, the appropriately substituted pyrroloaniline or 2-methoxy-5-phenylaniline. The pyrroloanilines were synthesized in two steps by treating the substituted nitroanilines with 2,5-dimethoxy-tetrahydrofuran to afford the nitropyrrole intermediates, followed by reduction of the nitro group with Raney Ni. The analogues were more potent than trimethoprim and epiroprim and more selective than TMQ and piritrexim against pcDHFR and tgDHFR. Compounds 5 and 10 had IC50 values of 1 and 0.64 μM, respectively, for the inhibition of the growth of T. gondii cells in culture, and showed excellent culture IC50/enzyme IC50 ratios, which were correlated with their calculated log P values, indicating a direct relationship between calculated lipephilicity and cell penetration.

Generation of the Neurotoxin 6-Hydroxydopamine by Peroxidase/H2O2 Oxidation of Dopamine

Napolitano, Alessandra,Crescenzi, Orlando,Pezzella, Alessandro,Prota, Giuseppe

, p. 917 - 922 (2007/10/02)

At physiological pH values, oxidation of the neurotransmitter dopamine(DA) by the peroxidase/H2O2 system leads to, besides dopaminochrome and 5,6-dihydroxyindole resulting from oxidative cyclization of dopaminequinone (DQ), significant amounts of the neurotoxin 6-hydroxydopamine (6-OHDA) in the oxidized quinonoid form (topaminequinone, TQ).Formation of TQ was shown to depend critically on the presence of hydrogen peroxide in the reaction medium and was not observed when DA oxidation was carried out using the tyrosinase/O2 system or chemical agents such as periodate or ferricyanide.These and other data suggest that, under the conditions adopted, nucleophilic attack of the hydrogen peroxide anion on DQ leading to TQ significantly competes with the intramolecular cyclization path.In line with this mechanism, the reaction course was not affected by the presence of hydroxyl radical scavengers.Peroxidase/H2O2 oxidation of the model N-acetyldopamine (1) gave, as expected, the 2-hydroxy-1,4-benzoquinone 3 in yields up to 55percent, depending on the catecholamine/H2O2 mole ratio.Likewise, reaction of 4-methyl-1,2-benzoquinone (4) with hydrogen peroxide afforded 2-hydroxy-5-methyl-1,4-benzoquinone (5) in good yields.Collectively, these results would point to the possibility that intraneuronal formation of 6-OHDA is associated with an increased production of hydrogen peroxide under oxidative stress conditions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15937-07-2